#begin document (en_1033.txt); part 000
en_1033.txt	0	0	Comeback	NNP	(TOP(NP*	-	-	-	-	*	-
en_1033.txt	0	1	Cancers	NNPS	*))	-	-	-	-	*	-

en_1033.txt	0	0	LONDON	NNP	(TOP(S(NP*	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	ONTARIO	NNP	(NP*	-	-	-	-	*	-
en_1033.txt	0	3	–	SYM	*	-	-	-	-	*	-
en_1033.txt	0	4	Progress	NNP	*))	-	-	-	-	*	-
en_1033.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	6	being	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	made	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	against	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	9	many	JJ	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	10	types	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	12	cancer	NN	(NP*))))	-	-	-	-	*	-
en_1033.txt	0	13	,	,	*	-	-	-	-	*	-
en_1033.txt	0	14	with	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	15	more	JJR	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	16	patients	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	17	surviving	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	18	longer	RBR	(ADVP*))))	-	-	-	-	*	-
en_1033.txt	0	19	,	,	*	-	-	-	-	*	-
en_1033.txt	0	20	thanks	NNS	(ADVP*	-	-	-	-	*	-
en_1033.txt	0	21	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	22	research	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	23	on	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	24	two	CD	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	25	fronts	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	26	:	:	*	-	-	-	-	*	-
en_1033.txt	0	27	improved	VBN	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	28	methods	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	29	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	30	earlier	JJR	(NP*	-	-	-	-	*	-
en_1033.txt	0	31	detection	NN	*)))	-	-	-	-	*	-
en_1033.txt	0	32	,	,	*	-	-	-	-	*	-
en_1033.txt	0	33	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	34	development	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	35	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	36	therapies	NNS	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	37	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	38	are	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	39	more	RBR	(ADJP(ADJP*	-	-	-	-	*	-
en_1033.txt	0	40	effective	JJ	*)	-	-	-	-	*	-
en_1033.txt	0	41	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	42	less	RBR	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	43	toxic	JJ	*))))))))))))))))	-	-	-	-	*	-
en_1033.txt	0	44	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Indeed	RB	(TOP(S(S(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	it	PRP	(NP*)	-	-	-	-	*	-
en_1033.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	estimated	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	5	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	6	there	EX	(S(NP*)	-	-	-	-	*	-
en_1033.txt	0	7	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	now	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	9	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_1033.txt	0	10	than	IN	*	-	-	-	-	*	-
en_1033.txt	0	11	10	CD	*	-	-	-	-	*	-
en_1033.txt	0	12	million	CD	*)	-	-	-	-	*	-
en_1033.txt	0	13	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	14	survivors	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	15	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	16	the	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	17	United	NNP	*	-	-	-	-	*	-
en_1033.txt	0	18	States	NNPS	*)))	-	-	-	-	*	-
en_1033.txt	0	19	alone	RB	(ADVP*)))))))	-	-	-	-	*	-
en_1033.txt	0	20	,	,	*	-	-	-	-	*	-
en_1033.txt	0	21	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	22	this	DT	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	23	number	NN	*)	-	-	-	-	*	-
en_1033.txt	0	24	has	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	25	been	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	26	steadily	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	27	increasing	VBG	(VP*))))	-	-	-	-	*	-
en_1033.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Similar	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1033.txt	0	1	numbers	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	2	,	,	*	-	-	-	-	*	-
en_1033.txt	0	3	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	4	proportion	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	5	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	6	population	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	7	sizes	NNS	*))))	-	-	-	-	*	-
en_1033.txt	0	8	,	,	*	-	-	-	-	*	-
en_1033.txt	0	9	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	10	found	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	12	other	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	13	developed	JJ	*	-	-	-	-	*	-
en_1033.txt	0	14	countries	NNS	*))))	-	-	-	-	*	-
en_1033.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Cancers	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	(0
en_1033.txt	0	1	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	2	are	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	3	detected	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	early	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	5	–	NN	*)	-	-	-	-	*	-
en_1033.txt	0	6	when	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1033.txt	0	7	they	PRP	(S(NP*)	-	-	-	-	*	(0)
en_1033.txt	0	8	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	9	small	JJ	(ADJP(ADJP*)	-	-	-	-	*	-
en_1033.txt	0	10	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	11	less	RBR	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	12	likely	JJ	*	-	-	-	-	*	-
en_1033.txt	0	13	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	14	have	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	15	metastasized	VBN	(VP(VP*)	-	-	-	-	*	-
en_1033.txt	0	16	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1033.txt	0	17	spread	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	18	away	RP	(PRT*)	-	-	-	-	*	-
en_1033.txt	0	19	from	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	20	the	DT	(NP*	-	-	-	-	*	(1
en_1033.txt	0	21	primary	JJ	*	-	-	-	-	*	-
en_1033.txt	0	22	tumor	NN	*)))	-	-	-	-	*	1)
en_1033.txt	0	23	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_1033.txt	0	24	–	SYM	(NP*)))))))))))))))	-	-	-	-	*	0)
en_1033.txt	0	25	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	26	more	RBR	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	27	likely	JJ	*	-	-	-	-	*	-
en_1033.txt	0	28	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	29	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	30	treatable	JJ	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	31	with	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	32	local	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	33	therapy	NN	*)))))))	-	-	-	-	*	-
en_1033.txt	0	34	,	,	*	-	-	-	-	*	-
en_1033.txt	0	35	whereas	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	36	successful	JJ	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	37	treatment	NN	*)	-	-	-	-	*	-
en_1033.txt	0	38	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	39	ultimately	RB	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	40	unlikely	JJ	*)	-	-	-	-	*	-
en_1033.txt	0	41	once	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	42	metastatic	JJ	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	43	tumors	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	44	develop	VBP	(VP*)))))))	-	-	-	-	*	-
en_1033.txt	0	45	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	And	CC	(TOP(S*	-	-	-	-	*	-
en_1033.txt	0	1	improved	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	2	therapies	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	3	mean	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	5	patients	NNS	(S(NP*)	-	-	-	-	*	(2)
en_1033.txt	0	6	can	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	treated	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	9	with	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	10	drugs	NNS	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	11	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	12	work	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	13	better	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	14	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1033.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	16	that	DT	(S(NP*	-	-	-	-	*	(2
en_1033.txt	0	17	patients	NNS	*)	-	-	-	-	*	2)
en_1033.txt	0	18	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	19	more	RBR	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	20	likely	JJ	*	-	-	-	-	*	-
en_1033.txt	0	21	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	22	receive	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	23	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	24	full	JJ	*	-	-	-	-	*	-
en_1033.txt	0	25	dose	NN	*)	-	-	-	-	*	-
en_1033.txt	0	26	needed	VBN	(VP*))))))))	-	-	-	-	*	-
en_1033.txt	0	27	-RRB-	-RRB-	*))))))))))))	-	-	-	-	*	-
en_1033.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	But	CC	(TOP(S(S*	-	-	-	-	*	-
en_1033.txt	0	1	our	PRP$	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	2	dramatic	JJ	*	-	-	-	-	*	-
en_1033.txt	0	3	progress	NN	*)	-	-	-	-	*	-
en_1033.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	5	detecting	VBG	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	7	treating	VBG	*	-	-	-	-	*	-
en_1033.txt	0	8	cancer	NN	(NP*)))))	-	-	-	-	*	-
en_1033.txt	0	9	has	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	10	also	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	11	led	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	12	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	13	growing	VBG	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	14	awareness	NN	*)	-	-	-	-	*	-
en_1033.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	16	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	17	problem	NN	*)	-	-	-	-	*	-
en_1033.txt	0	18	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	19	tumor	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	20	dormancy	NN	*)))))))))	-	-	-	-	*	-
en_1033.txt	0	21	:	:	*	-	-	-	-	*	-
en_1033.txt	0	22	a	DT	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	23	patient	NN	*)	-	-	-	-	*	-
en_1033.txt	0	24	appears	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	25	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	26	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	27	cured	VBN	(VP*))))	-	-	-	-	*	-
en_1033.txt	0	28	,	,	*	-	-	-	-	*	-
en_1033.txt	0	29	only	RB	(S(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	30	to	TO	(VP*	-	-	-	-	*	-
en_1033.txt	0	31	have	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	32	the	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	33	same	JJ	*	-	-	-	-	*	-
en_1033.txt	0	34	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	35	return	NN	*)	-	-	-	-	*	-
en_1033.txt	0	36	years	NNS	(UCP(NP*)	-	-	-	-	*	-
en_1033.txt	0	37	or	CC	*	-	-	-	-	*	-
en_1033.txt	0	38	even	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	39	decades	NNS	(ADVP(NP*)	-	-	-	-	*	-
en_1033.txt	0	40	later	RB	*)))))))	-	-	-	-	*	-
en_1033.txt	0	41	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1033.txt	0	1	breast	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	2	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	3	or	CC	*	-	-	-	-	*	-
en_1033.txt	0	4	melanoma	NN	*))	-	-	-	-	*	-
en_1033.txt	0	5	,	,	*	-	-	-	-	*	-
en_1033.txt	0	6	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	7	example	NN	(NP*))	-	-	-	-	*	-
en_1033.txt	0	8	,	,	*	-	-	-	-	*	-
en_1033.txt	0	9	recurrences	NNS	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	10	25	CD	(PP(NP*	-	-	-	-	*	-
en_1033.txt	0	11	years	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	12	after	IN	*	-	-	-	-	*	-
en_1033.txt	0	13	initial	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	14	treatment	NN	*)))	-	-	-	-	*	-
en_1033.txt	0	15	have	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	16	been	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	17	reported	VBN	(VP*)))	-	-	-	-	*	-
en_1033.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	With	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1033.txt	0	1	a	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	2	growing	VBG	*	-	-	-	-	*	-
en_1033.txt	0	3	number	NN	*)	-	-	-	-	*	-
en_1033.txt	0	4	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	5	cancer	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	6	survivors	NNS	*))))	-	-	-	-	*	-
en_1033.txt	0	7	,	,	*	-	-	-	-	*	-
en_1033.txt	0	8	we	PRP	(NP*)	-	-	-	-	*	-
en_1033.txt	0	9	need	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	11	understand	VB	(VP(VP*	-	-	-	-	*	-
en_1033.txt	0	12	better	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	13	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	14	twin	JJ	*	-	-	-	-	*	-
en_1033.txt	0	15	processes	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	17	tumor	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	18	dormancy	NN	*))))	-	-	-	-	*	-
en_1033.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	20	metastatic	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	21	cancer	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	22	recurrence	NN	*))))))	-	-	-	-	*	-
en_1033.txt	0	23	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	While	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_1033.txt	0	1	remarkable	JJ	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	2	progress	NN	*)	-	-	-	-	*	-
en_1033.txt	0	3	has	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	been	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	5	made	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	7	understanding	VBG	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	8	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	9	biology	NN	*)	-	-	-	-	*	-
en_1033.txt	0	10	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	11	cancer	NN	(NP*)))	-	-	-	-	*	-
en_1033.txt	0	12	–	SYM	(X*)	-	-	-	-	*	-
en_1033.txt	0	13	leading	VBG	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	15	part	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	16	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	17	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	18	development	NN	*)	-	-	-	-	*	-
en_1033.txt	0	19	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	20	new	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	21	,	,	*	-	-	-	-	*	-
en_1033.txt	0	22	less	RBR	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	23	toxic	JJ	*)	-	-	-	-	*	-
en_1033.txt	0	24	drugs	NNS	*))))))))	-	-	-	-	*	-
en_1033.txt	0	25	–	SYM	(X(X*)	-	-	-	-	*	-
en_1033.txt	0	26	our	PRP$	(NP(NP*	-	-	-	-	*	(3)
en_1033.txt	0	27	understanding	NN	*)	-	-	-	-	*	-
en_1033.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	29	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	30	biology	NN	*)	-	-	-	-	*	-
en_1033.txt	0	31	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	32	tumor	NN	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	33	metastasis	NN	*)	-	-	-	-	*	-
en_1033.txt	0	34	,	,	*	-	-	-	-	*	-
en_1033.txt	0	35	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	36	especially	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	37	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	38	development	NN	*)	-	-	-	-	*	-
en_1033.txt	0	39	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	40	metastases	NNS	(NP*)))))))))	-	-	-	-	*	-
en_1033.txt	0	41	after	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	42	a	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	43	long	JJ	*	-	-	-	-	*	-
en_1033.txt	0	44	period	NN	*)	-	-	-	-	*	-
en_1033.txt	0	45	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	46	tumor	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	47	dormancy	NN	*))))))))))))	-	-	-	-	*	-
en_1033.txt	0	48	,	,	*	-	-	-	-	*	-
en_1033.txt	0	49	has	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	50	lagged	VBN	(VP*))	-	-	-	-	*	-
en_1033.txt	0	51	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	1	do	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	2	know	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	4	metastasis	NN	(S(NP*)	-	-	-	-	*	-
en_1033.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	6	a	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	7	very	RB	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	8	inefficient	JJ	*)	-	-	-	-	*	-
en_1033.txt	0	9	process	NN	*)	-	-	-	-	*	-
en_1033.txt	0	10	,	,	*	-	-	-	-	*	-
en_1033.txt	0	11	with	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	12	most	JJS	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	13	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	14	cells	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	15	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	16	escape	VB	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	17	into	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	18	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	19	blood	NN	*	-	-	-	-	*	-
en_1033.txt	0	20	stream	NN	*)	-	-	-	-	*	-
en_1033.txt	0	21	failing	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	22	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	23	form	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	24	metastatic	JJ	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	25	tumors	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	26	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	27	distant	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	28	organs	NNS	*)))))))))))))))))))	-	-	-	-	*	-
en_1033.txt	0	29	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Recent	JJ	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	1	studies	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	2	–	SYM	(X*)	-	-	-	-	*	-
en_1033.txt	0	3	from	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	4	both	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	5	the	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	6	laboratory	NN	*)	-	-	-	-	*	-
en_1033.txt	0	7	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	8	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	9	clinic	NN	*)	-	-	-	-	*	-
en_1033.txt	0	10	–	SYM	(X*)))))	-	-	-	-	*	-
en_1033.txt	0	11	suggest	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	12	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	13	many	JJ	(S(NP(NP*	-	-	-	-	*	(4
en_1033.txt	0	14	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	15	cells	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	16	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	17	leave	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	18	the	DT	(NP*	-	-	-	-	*	(1
en_1033.txt	0	19	primary	JJ	*	-	-	-	-	*	-
en_1033.txt	0	20	tumor	NN	*)))))	-	-	-	-	*	4)|1)
en_1033.txt	0	21	may	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	22	lodge	VB	(VP(VP*	-	-	-	-	*	-
en_1033.txt	0	23	themselves	PRP	(NP*)	-	-	-	-	*	(4)
en_1033.txt	0	24	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	25	new	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	26	organs	NNS	*)))	-	-	-	-	*	-
en_1033.txt	0	27	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	28	go	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	29	into	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	30	a	DT	(NP*	-	-	-	-	*	(5
en_1033.txt	0	31	dormant	JJ	*	-	-	-	-	*	-
en_1033.txt	0	32	state	NN	*))))))))	-	-	-	-	*	5)
en_1033.txt	0	33	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	1	also	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	2	have	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	3	evidence	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	4	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	5	says	VBZ	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	7	these	DT	(S(NP*	-	-	-	-	*	(4
en_1033.txt	0	8	dormant	JJ	*	-	-	-	-	*	-
en_1033.txt	0	9	cells	NNS	*)	-	-	-	-	*	4)
en_1033.txt	0	10	may	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	11	resist	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	12	most	JJS	(NP*	-	-	-	-	*	(6
en_1033.txt	0	13	current	JJ	*	-	-	-	-	*	-
en_1033.txt	0	14	treatments	NNS	*))))))))))	-	-	-	-	*	6)
en_1033.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_1033.txt	0	1	means	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	2	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	3	adjuvant	JJ	(S(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	4	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	5	therapy	NN	*)	-	-	-	-	*	-
en_1033.txt	0	6	,	,	*	-	-	-	-	*	-
en_1033.txt	0	7	designed	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	9	kill	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	10	presumed	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	11	micrometastatic	NN	*	-	-	-	-	*	-
en_1033.txt	0	12	disease	NN	*)))))	-	-	-	-	*	-
en_1033.txt	0	13	,	,	*)	-	-	-	-	*	-
en_1033.txt	0	14	may	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	15	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	16	missing	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	17	an	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	18	important	JJ	*	-	-	-	-	*	-
en_1033.txt	0	19	fraction	NN	*)	-	-	-	-	*	-
en_1033.txt	0	20	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	21	disseminated	VBN	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	22	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	23	cells	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	24	,	,	*	-	-	-	-	*	-
en_1033.txt	0	25	some	DT	(SBAR(WHNP*	-	-	-	-	*	-
en_1033.txt	0	26	of	IN	(WHPP*	-	-	-	-	*	-
en_1033.txt	0	27	which	WDT	(WHNP*)))	-	-	-	-	*	-
en_1033.txt	0	28	may	MD	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	29	eventually	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	30	wake	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	31	up	RP	(PRT*))))))))))))))	-	-	-	-	*	-
en_1033.txt	0	32	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Moreover	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	we	PRP	(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	3	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	beginning	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	6	identify	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	molecular	JJ	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	8	mechanisms	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	9	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	10	regulate	VB	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	11	the	DT	(NP(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	12	entry	NN	*)	-	-	-	-	*	-
en_1033.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	14	cancer	NN	(NP*	-	-	-	-	*	(7
en_1033.txt	0	15	cells	NNS	*))	-	-	-	-	*	7)
en_1033.txt	0	16	into	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	17	a	DT	(NP*	-	-	-	-	*	(5
en_1033.txt	0	18	dormant	JJ	*	-	-	-	-	*	-
en_1033.txt	0	19	state	NN	*)))	-	-	-	-	*	5)
en_1033.txt	0	20	,	,	*	-	-	-	-	*	-
en_1033.txt	0	21	as	RB	(CONJP*	-	-	-	-	*	-
en_1033.txt	0	22	well	RB	*	-	-	-	-	*	-
en_1033.txt	0	23	as	IN	*)	-	-	-	-	*	-
en_1033.txt	0	24	their	PRP$	(NP(NP*	-	-	-	-	*	(7)
en_1033.txt	0	25	re-awakening	NN	*)	-	-	-	-	*	-
en_1033.txt	0	26	at	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	27	later	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	28	times	NNS	*)))))))))))))	-	-	-	-	*	-
en_1033.txt	0	29	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Our	PRP$	(TOP(S(NP(NP*	-	-	-	-	*	(8|(3)
en_1033.txt	0	1	knowledge	NN	*)	-	-	-	-	*	-
en_1033.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	4	regulation	NN	*)	-	-	-	-	*	-
en_1033.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	6	tumor	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	7	dormancy	NN	*)))))	-	-	-	-	*	8)
en_1033.txt	0	8	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	9	really	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	10	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	11	its	PRP$	(NP*	-	-	-	-	*	(8)
en_1033.txt	0	12	infancy	NN	*)))	-	-	-	-	*	-
en_1033.txt	0	13	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	given	VBN	(PP*	-	-	-	-	*	-
en_1033.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	4	growing	VBG	*	-	-	-	-	*	-
en_1033.txt	0	5	numbers	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	7	cancer	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	8	survivors	NNS	*))))	-	-	-	-	*	-
en_1033.txt	0	9	,	,	*	-	-	-	-	*	-
en_1033.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	11	need	NN	*)	-	-	-	-	*	-
en_1033.txt	0	12	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	13	this	DT	(NP*	-	-	-	-	*	(8
en_1033.txt	0	14	knowledge	NN	*)))	-	-	-	-	*	8)
en_1033.txt	0	15	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	16	becoming	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	17	more	RBR	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	18	pressing	JJ	*)))	-	-	-	-	*	-
en_1033.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Indeed	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	there	EX	(NP*)	-	-	-	-	*	-
en_1033.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	evidence	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	5	suggesting	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	6	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	7	tumor	NN	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	8	dormancy	NN	*)	-	-	-	-	*	-
en_1033.txt	0	9	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	10	a	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	11	valid	JJ	*	-	-	-	-	*	-
en_1033.txt	0	12	target	NN	*)	-	-	-	-	*	-
en_1033.txt	0	13	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	14	therapy	NN	(NP*)))))))))	-	-	-	-	*	-
en_1033.txt	0	15	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	For	IN	(TOP(S(S(PP*	-	-	-	-	*	-
en_1033.txt	0	1	example	NN	(NP*))	-	-	-	-	*	-
en_1033.txt	0	2	,	,	*	-	-	-	-	*	-
en_1033.txt	0	3	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	4	some	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	5	types	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	7	breast	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	8	cancer	NN	*))))	-	-	-	-	*	-
en_1033.txt	0	9	,	,	*	-	-	-	-	*	-
en_1033.txt	0	10	patients	NNS	(NP*)	-	-	-	-	*	-
en_1033.txt	0	11	may	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	12	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	13	treated	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	14	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	15	more	JJR	(NP(QP*	-	-	-	-	*	-
en_1033.txt	0	16	than	IN	*	-	-	-	-	*	-
en_1033.txt	0	17	a	DT	*)	-	-	-	-	*	-
en_1033.txt	0	18	decade	NN	*))	-	-	-	-	*	-
en_1033.txt	0	19	with	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	20	anti-hormone	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	21	therapies	NNS	*))))))	-	-	-	-	*	-
en_1033.txt	0	22	,	,	*	-	-	-	-	*	-
en_1033.txt	0	23	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	24	these	DT	(S(NP*	-	-	-	-	*	(6
en_1033.txt	0	25	long-term	JJ	*	-	-	-	-	*	-
en_1033.txt	0	26	treatments	NNS	*)	-	-	-	-	*	6)
en_1033.txt	0	27	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	28	working	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	29	–	SYM	(SBAR(X*)	-	-	-	-	*	-
en_1033.txt	0	30	they	PRP	(S(NP*)	-	-	-	-	*	(6)
en_1033.txt	0	31	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	32	successful	JJ	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	33	at	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	34	preventing	VBG	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	35	some	DT	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	36	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	37	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	38	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	39	recurrences	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	40	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	41	occur	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	42	with	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	43	shorter	JJR	(NP*	-	-	-	-	*	-
en_1033.txt	0	44	treatment	NN	*))))))))))))))))))	-	-	-	-	*	-
en_1033.txt	0	45	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	while	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	3	these	DT	(S(NP*	-	-	-	-	*	(9
en_1033.txt	0	4	long-term	JJ	*	-	-	-	-	*	-
en_1033.txt	0	5	therapies	NNS	*)	-	-	-	-	*	9)
en_1033.txt	0	6	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	relatively	RB	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	8	safe	JJ	*))))	-	-	-	-	*	-
en_1033.txt	0	9	,	,	*	-	-	-	-	*	-
en_1033.txt	0	10	they	PRP	(S(NP*)	-	-	-	-	*	(9)
en_1033.txt	0	11	do	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	12	have	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	13	side-effects	NNS	(NP*))))	-	-	-	-	*	-
en_1033.txt	0	14	,	,	*	-	-	-	-	*	-
en_1033.txt	0	15	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	16	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	17	number	NN	*)	-	-	-	-	*	-
en_1033.txt	0	18	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	19	cancer	NN	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	20	recurrences	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	21	that	IN	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	22	they	PRP	(S(NP*)	-	-	-	-	*	(9)
en_1033.txt	0	23	prevent	VBP	(VP*))))))	-	-	-	-	*	-
en_1033.txt	0	24	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	25	small	JJ	(ADJP*)))	-	-	-	-	*	-
en_1033.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1033.txt	0	1	challenge	NN	*)	-	-	-	-	*	-
en_1033.txt	0	2	today	NN	(NP*)	-	-	-	-	*	-
en_1033.txt	0	3	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	thus	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	6	understand	VB	(VP(VP*	-	-	-	-	*	-
en_1033.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	8	processes	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	10	tumor	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	11	dormancy	NN	*))))	-	-	-	-	*	-
en_1033.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	13	metastasis	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	14	better	RBR	(ADVP*)))))	-	-	-	-	*	-
en_1033.txt	0	15	,	,	*	-	-	-	-	*	-
en_1033.txt	0	16	in	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	17	order	NN	*	-	-	-	-	*	-
en_1033.txt	0	18	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	19	determine	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	20	more	RBR	(ADVP*	-	-	-	-	*	-
en_1033.txt	0	21	accurately	RB	*)	-	-	-	-	*	-
en_1033.txt	0	22	which	WDT	(SBAR(WHNP*	-	-	-	-	*	-
en_1033.txt	0	23	patients	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	24	will	MD	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	25	benefit	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	26	from	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	27	long-term	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	28	therapy	NN	*)))))))))))	-	-	-	-	*	-
en_1033.txt	0	29	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	We	PRP	(TOP(S(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	1	have	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	2	much	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	3	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	4	learn	VB	(VP*)))))	-	-	-	-	*	-
en_1033.txt	0	5	,	,	*	-	-	-	-	*	-
en_1033.txt	0	6	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	7	at	IN	(S(PP*	-	-	-	-	*	-
en_1033.txt	0	8	this	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	9	stage	NN	*))	-	-	-	-	*	-
en_1033.txt	0	10	don	NNS	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	11	'	POS	*)	-	-	-	-	*	-
en_1033.txt	0	12	t	NN	*)	-	-	-	-	*	-
en_1033.txt	0	13	even	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	14	know	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	15	all	DT	(S(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	17	the	DT	(NP*	-	-	-	-	*	(10
en_1033.txt	0	18	questions	NNS	*)))	-	-	-	-	*	10)
en_1033.txt	0	19	to	TO	(VP*	-	-	-	-	*	-
en_1033.txt	0	20	ask	VB	(VP*)))))	-	-	-	-	*	-
en_1033.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Would	MD	(TOP(SQ*	-	-	-	-	*	-
en_1033.txt	0	1	intermittent	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	2	therapy	NN	*)	-	-	-	-	*	-
en_1033.txt	0	3	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	as	RB	(ADJP(ADJP*	-	-	-	-	*	-
en_1033.txt	0	5	useful	JJ	*)	-	-	-	-	*	-
en_1033.txt	0	6	as	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	7	long-term	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	8	treatment	NN	*))))	-	-	-	-	*	-
en_1033.txt	0	9	?	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Are	VBP	(TOP(SQ*	-	-	-	-	*	-
en_1033.txt	0	1	there	EX	(NP*)	-	-	-	-	*	-
en_1033.txt	0	2	features	NNS	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	3	of	IN	(PP(PP*	-	-	-	-	*	-
en_1033.txt	0	4	the	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	5	primary	JJ	*	-	-	-	-	*	-
en_1033.txt	0	6	cancer	NN	*))	-	-	-	-	*	-
en_1033.txt	0	7	,	,	*	-	-	-	-	*	-
en_1033.txt	0	8	or	CC	*	-	-	-	-	*	-
en_1033.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	10	individual	JJ	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	11	patients	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	12	,	,	*	-	-	-	-	*	-
en_1033.txt	0	13	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	14	can	MD	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	15	help	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	16	us	PRP	(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	17	predict	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	18	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	19	will	MD	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	20	develop	VB	(VP(VP*	-	-	-	-	*	-
en_1033.txt	0	21	late	JJ	(NP*	-	-	-	-	*	(11
en_1033.txt	0	22	recurrences	NNS	*))	-	-	-	-	*	11)
en_1033.txt	0	23	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	24	metastatic	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	25	disease	NN	(NP*))))))))))))))))	-	-	-	-	*	-
en_1033.txt	0	26	?	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	What	WP	(TOP(FRAG(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	1	if	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	2	late	JJ	(S(NP*	-	-	-	-	*	(11
en_1033.txt	0	3	recurrences	NNS	*)	-	-	-	-	*	11)
en_1033.txt	0	4	simply	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	5	cannot	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	6	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	predicted	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	at	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	9	diagnosis	NN	(NP*)))))))	-	-	-	-	*	-
en_1033.txt	0	10	?	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Are	VBP	(TOP(SQ*	-	-	-	-	*	-
en_1033.txt	0	1	there	EX	(NP*)	-	-	-	-	*	-
en_1033.txt	0	2	modifiable	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	3	factors	NNS	(NP*))	-	-	-	-	*	-
en_1033.txt	0	4	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	5	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	6	example	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	7	,	,	*	-	-	-	-	*	-
en_1033.txt	0	8	lifestyle	NN	(NP*)	-	-	-	-	*	-
en_1033.txt	0	9	,	,	*	-	-	-	-	*	-
en_1033.txt	0	10	immune-system	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	11	status	NN	*)	-	-	-	-	*	-
en_1033.txt	0	12	,	,	*	-	-	-	-	*	-
en_1033.txt	0	13	or	CC	*	-	-	-	-	*	-
en_1033.txt	0	14	environmental	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	15	conditions	NNS	*))))	-	-	-	-	*	-
en_1033.txt	0	16	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	17	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	18	influence	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	19	whether	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	20	or	CC	*	-	-	-	-	*	-
en_1033.txt	0	21	not	RB	*	-	-	-	-	*	-
en_1033.txt	0	22	patients	NNS	(S(NP*)	-	-	-	-	*	-
en_1033.txt	0	23	develop	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	24	late	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	25	recurrences	NNS	*))))))))	-	-	-	-	*	-
en_1033.txt	0	26	?	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	The	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	1	answers	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	2	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	3	these	DT	(NP*	-	-	-	-	*	(10
en_1033.txt	0	4	questions	NNS	*)))	-	-	-	-	*	10)
en_1033.txt	0	5	will	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	6	require	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	research	NN	(NP*))))	-	-	-	-	*	-
en_1033.txt	0	8	,	,	*	-	-	-	-	*	-
en_1033.txt	0	9	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	10	research	NN	(S(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	11	into	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	12	metastasis	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	14	tumor	NN	(NP*	-	-	-	-	*	(12
en_1033.txt	0	15	dormancy	NN	*))))	-	-	-	-	*	12)
en_1033.txt	0	16	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	17	difficult	JJ	(ADJP*)))	-	-	-	-	*	-
en_1033.txt	0	18	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	It	PRP	(TOP(S(NP*)	-	-	-	-	*	(12)
en_1033.txt	0	1	requires	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	2	patience	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	3	,	,	*	-	-	-	-	*	-
en_1033.txt	0	4	development	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	6	models	NNS	(NP*)))	-	-	-	-	*	-
en_1033.txt	0	7	,	,	*	-	-	-	-	*	-
en_1033.txt	0	8	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	9	willingness	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	10	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	11	undertake	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	12	long-term	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	13	studies	NNS	*)))))))	-	-	-	-	*	-
en_1033.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	1	also	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	2	need	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	3	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	4	understand	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	5	better	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	7	prevalence	NN	*)	-	-	-	-	*	-
en_1033.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	9	long-term	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	10	dormant	JJ	*	-	-	-	-	*	-
en_1033.txt	0	11	disease	NN	*))	-	-	-	-	*	-
en_1033.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	13	patients	NNS	(NP*)))))))	-	-	-	-	*	-
en_1033.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	How	WRB	(TOP(SBARQ(WHADVP*	-	-	-	-	*	-
en_1033.txt	0	1	common	JJ	*)	-	-	-	-	*	-
en_1033.txt	0	2	is	VBZ	(SQ(VP*	-	-	-	-	*	-
en_1033.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	4	phenomenon	NN	*)	-	-	-	-	*	-
en_1033.txt	0	5	we	PRP	(SBAR(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	6	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	examining	VBG	(VP*)))))))	-	-	-	-	*	-
en_1033.txt	0	8	?	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	It	PRP	(TOP(S(S(NP*)	-	-	-	-	*	-
en_1033.txt	0	1	may	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	2	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	4	many	JJ	(S(NP*	-	-	-	-	*	-
en_1033.txt	0	5	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	6	patients	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	7	harbor	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	disseminated	VBN	(NP*	-	-	-	-	*	-
en_1033.txt	0	9	tumor	NN	*	-	-	-	-	*	-
en_1033.txt	0	10	cells	NNS	*)))))))	-	-	-	-	*	-
en_1033.txt	0	11	,	,	*	-	-	-	-	*	-
en_1033.txt	0	12	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	13	not	RB	(S(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	14	all	DT	*)	-	-	-	-	*	-
en_1033.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	16	these	DT	(NP*	-	-	-	-	*	(4
en_1033.txt	0	17	cells	NNS	*)))	-	-	-	-	*	4)
en_1033.txt	0	18	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	19	destined	VBN	(VP*	-	-	-	-	*	-
en_1033.txt	0	20	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	21	re-awaken	NN	(NP*)))))	-	-	-	-	*	-
en_1033.txt	0	22	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1033.txt	0	1	some	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	2	ways	NNS	*))	-	-	-	-	*	-
en_1033.txt	0	3	,	,	*	-	-	-	-	*	-
en_1033.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	5	success	NN	*)	-	-	-	-	*	-
en_1033.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	7	cancer	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	8	research	NN	*)))	-	-	-	-	*	-
en_1033.txt	0	9	is	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	10	fueling	VBG	(VP*	-	-	-	-	*	-
en_1033.txt	0	11	pressure	NN	(NP*)	-	-	-	-	*	-
en_1033.txt	0	12	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	13	``	``	(VP*	-	-	-	-	*	-
en_1033.txt	0	14	cure	VB	*	-	-	-	-	*	-
en_1033.txt	0	15	''	''	*	-	-	-	-	*	-
en_1033.txt	0	16	cancer	NN	(NP*)	-	-	-	-	*	-
en_1033.txt	0	17	quickly	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	18	,	,	*	-	-	-	-	*	-
en_1033.txt	0	19	steering	VBG	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	20	clinical	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	21	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	22	laboratory	NN	*	-	-	-	-	*	-
en_1033.txt	0	23	researchers	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	24	away	RB	(ADVP*	-	-	-	-	*	-
en_1033.txt	0	25	from	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	26	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	27	tricky	JJ	*	-	-	-	-	*	-
en_1033.txt	0	28	problems	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	29	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	30	metastasis	NN	(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	31	and	CC	*	-	-	-	-	*	-
en_1033.txt	0	32	long-term	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	33	tumor	NN	*	-	-	-	-	*	-
en_1033.txt	0	34	dormancy	NN	*)))))))))))))	-	-	-	-	*	-
en_1033.txt	0	35	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	This	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1033.txt	0	1	focus	NN	*)	-	-	-	-	*	-
en_1033.txt	0	2	ultimately	RB	(ADVP*)	-	-	-	-	*	-
en_1033.txt	0	3	may	MD	(VP*	-	-	-	-	*	-
en_1033.txt	0	4	be	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	5	shortsighted	JJ	(ADJP*)	-	-	-	-	*	-
en_1033.txt	0	6	,	,	*	-	-	-	-	*	-
en_1033.txt	0	7	as	IN	(SBAR*	-	-	-	-	*	-
en_1033.txt	0	8	the	DT	(S(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	9	increasing	VBG	*	-	-	-	-	*	-
en_1033.txt	0	10	number	NN	*)	-	-	-	-	*	-
en_1033.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	12	cancer	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	13	survivors	NNS	*)))	-	-	-	-	*	-
en_1033.txt	0	14	leads	VBZ	(VP*	-	-	-	-	*	-
en_1033.txt	0	15	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	16	an	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	17	increase	NN	*)	-	-	-	-	*	-
en_1033.txt	0	18	in	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	19	late	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	20	recurrences	NNS	*)))))))))	-	-	-	-	*	-
en_1033.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	Metastases	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1033.txt	0	1	,	,	*	-	-	-	-	*	-
en_1033.txt	0	2	not	RB	*	-	-	-	-	*	-
en_1033.txt	0	3	the	DT	(NP*	-	-	-	-	*	-
en_1033.txt	0	4	primary	JJ	*	-	-	-	-	*	-
en_1033.txt	0	5	tumor	NN	*)	-	-	-	-	*	-
en_1033.txt	0	6	,	,	*)	-	-	-	-	*	-
en_1033.txt	0	7	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	8	responsible	JJ	(ADJP*	-	-	-	-	*	-
en_1033.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	10	most	JJS	(NP*	-	-	-	-	*	-
en_1033.txt	0	11	cancer	NN	*	-	-	-	-	*	-
en_1033.txt	0	12	deaths	NNS	*))))	-	-	-	-	*	-
en_1033.txt	0	13	.	.	*))	-	-	-	-	*	-

en_1033.txt	0	0	If	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_1033.txt	0	1	we	PRP	(S(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	2	are	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	3	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	4	continue	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	5	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	6	improve	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	7	on	IN	(PP*	-	-	-	-	*	-
en_1033.txt	0	8	cancer	NN	(NP*	-	-	-	-	*	-
en_1033.txt	0	9	survival	NN	*	-	-	-	-	*	-
en_1033.txt	0	10	statistics	NNS	*)))))))))))	-	-	-	-	*	-
en_1033.txt	0	11	,	,	*	-	-	-	-	*	-
en_1033.txt	0	12	we	PRP	(NP*)	-	-	-	-	*	(3)
en_1033.txt	0	13	need	VBP	(VP*	-	-	-	-	*	-
en_1033.txt	0	14	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	15	learn	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	16	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1033.txt	0	17	to	TO	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	18	prevent	VB	(VP*	-	-	-	-	*	-
en_1033.txt	0	19	,	,	*	-	-	-	-	*	-
en_1033.txt	0	20	delay	VB	*	-	-	-	-	*	-
en_1033.txt	0	21	,	,	*	-	-	-	-	*	-
en_1033.txt	0	22	or	CC	*	-	-	-	-	*	-
en_1033.txt	0	23	thwart	VB	*	-	-	-	-	*	-
en_1033.txt	0	24	the	DT	(NP(NP*	-	-	-	-	*	-
en_1033.txt	0	25	processes	NNS	*)	-	-	-	-	*	-
en_1033.txt	0	26	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1033.txt	0	27	give	VBP	(S(VP*	-	-	-	-	*	-
en_1033.txt	0	28	rise	NN	(NP*)	-	-	-	-	*	-
en_1033.txt	0	29	to	TO	(PP*	-	-	-	-	*	-
en_1033.txt	0	30	metastatic	JJ	(NP*	-	-	-	-	*	-
en_1033.txt	0	31	disease	NN	*))))))))))))))	-	-	-	-	*	-
en_1033.txt	0	32	.	.	*))	-	-	-	-	*	-

#end document
